Becky Hussey has been announced as the winner of the 2011 Royal Canin Pet Health Counsellor of the Year Award. Second prize was awarded to Sian Ferris from The Smart Clinic in Cardiff and third place to Lana Goulding of Claremont Vet Group, Bexhill-on-Sea.
The PHC of the Year scheme has been running for over sixteen years and this year saw a record number of entrants for judge and well-known pet behaviourist Sarah Heath, BVSc, MRCVS, to assess. As part of the initiative, participants receive specialist training of a wide variety of topics, highly relevant to veterinary nurses' growing involvement in veterinary practice. The original aim of the PHC programme was to help veterinary nurses to improve their knowledge and skills to enable them to be even more confident when advising clients and developing clinics. Whilst this aim still holds true, a veterinary nurse achieving PHC status is now widely recognised as a valuable asset to a practice, as well as significantly enhancing personal development.
Becky's entry this year detailed the many activities she undertakes, in addition to her daily duties, at the practice where she works. They included various client pet clinics, a "Choose a pet" advice service, client competitions, numerous advertorials to help raise the practice group's profile and lots of charity fund-raising. She was also part of the team whose hard work resulted in the practice being granted RCVS Accreditation.
Pet owners who believe in preventative healthcare have maintained or increased the money they spend on their pets this year, and 84% visited their vet at least once in 2010, up from 78% in 2007, according to a survey commissioned by the National Office of Animal Health.
According to the survey of 1000 owners carried out by Noesis, 44% of 'preventers' increased their spending on their pets in the last year with only a very small number (5%) decreasing it. There has also been a significant increase in the number of dogs insured by this group since 2007, which now stands at 55% compared to 41% in 2007.
The research covered both 'preventer' and 'non-preventer pet owners and sought to understand: awareness of preventative medicine in cats and dogs; how the decision is made as to what areas of preventative medicine are important and which to adopt; what types of preventative medicine are carried out and the reasons and frequency of this behaviour as well as the sources of information.
In addition to visiting their vet more frequently and spending more on their pets, preventers also visited a pet shop significantly more often than non-preventers with nearly two thirds (61%) of preventers visiting at least once a month compared to 36% of non-preventers, a figure that has decreased from 43% in 2007.
Looking at specific preventative treatments, attitudes to vaccination had not changed between the 2007 and 2010 surveys, with preventers believing that being a responsible pet owner means regularly vaccinating your pet, while non-preventers did not believe vaccination was relevant to their situation. This points to a clear need to educate non-preventers to break habits that have sometimes been handed down from generation to generation.
Most owners from both groups had used a flea treatment on their pets in the past two years although 68% of preventers were much more proactive in their usage of flea products compared to only 40% of non-preventers. Cats (80%) are more likely to have been treated than dogs (69%) among both groups of owners although flea treatment of cats has significantly decreased among non-preventers since 2007.
Use of wormers was also in decline. Although 86% of preventers worm proactively as part of a healthcare routine for their pet, this figure has decreased from 96% in 2007. Non preventers chose not to worm because they did not see the need, citing reasons such as their pet being fit and well or not going outdoors. Likewise, although preventers are more likely than non-preventers to be aware of the zoonotic implications of pet parasites, this awareness had decreased since 2007 pointing to the need for more work to be done on this aspect of pet health. On a more upbeat note, those that were worming proactively wormed their pets more frequently with 50% worming at least every three months in 2010 which was significantly more than compared to 41% in 2007.
When asked where they obtained general healthcare advice, the vet was the most frequently cited source of information with 84% of preventers and 58% of non-preventers referencing their vet. The internet is an increasingly important information channel for non-preventers with almost a third (31%) citing it as their source for pet healthcare advice, an increase from 25% in 2007.
There was huge interest from both groups (87% of preventers and 79% of non-preventers) in using a dedicated website such as NOAH's http://www.pethealthinfo.org.uk/ which 10% of the pet owners surveyed had heard of. It was welcomed for providing easy access, immediate, independent advice and being written by veterinary experts.
Commenting on the research, Phil Sketchley, chief executive of NOAH said: "We commissioned the original piece of research in 2007 to understand the differences between both groups of pet owners and understand where they sourced their information in order to influence the pet healthcare habits of the non-preventers in particular. The importance of the internet as a source of information proved that our strategy to launch http://www.pethealthinfo.org.uk/ was on target and the latest survey shows that this channel is increasingly important, particularly among non-preventers.
"The 2011 survey also reveals some positive insights into the preventative healthcare habits of those pet owners that we termed preventers. This group are more likely to insure their pet (45% vs 12%), go to the vet at least once a year (84% vs 30%) and visit a pet shop at least on a monthly basis (61% vs 36%). And, as a final piece of good news, this group have increased their total spend on their pets in the last year and very few members of either group had decreased their spend.
"Whilst all pet owners consider themselves responsible clearly some do not see regular preventative healthcare as part of that responsibility. So there remains a clear need to educate pet owners, particularly the non-preventers, to change some of the patterns of behaviour and complacency regarding their pet's health that have become entrenched and seem to have been influenced by friends and family."
Vetoquinol has announced the launch of Equistro Flexadin UCII, an equine joint supplement.
Equistro Flexadin UCII contains a new ingredient, UC-II, which the company claims is one of the most effective and influential ingredients available that aids and supports healthy joint function.
To celebrate the launch of Flexadin UCII Vetoquinol is offering a £10 money off voucher available through purchases of Horse & Hound magazine starting from November 10th.
Caitríona Mullin, Equine Product Manager at Vetoquinol UK Ltd said: "We are very excited about the launch of Flexadin UCII in the UK and Ireland, we have already received excellent feedback from our German and French colleagues. Flexadin UCII is a product that will further enhance our premium range of equine supplements formulated specifically for the performance horse."
A research project funded by equine charity The Horse Trust has found that lameness is the most common reason for euthanasing a geriatric horse.
According to the charity, this research is the first in the UK to provide data on the causes of death in geriatric horses. Although post-mortem studies have provided some data regarding causes of death, "old age" was previously reported as a common reason for the euthanasia of adult horses.
The research was carried out by Joanne Ireland at the University of Liverpool and led by Dr Gina Pinchbeck. Ireland surveyed horse owners living in the North-West and Midlands areas of England and North Wales who have a horse aged 15 years or older. 918 owners of geriatric horses were followed in a cohort study and 118 mortalities were reported during the 18 month follow-up period, of which 111 were euthanased.
The researchers found that 24% of horses were euthanased due to lameness; an additional 12% were euthanased due to laminitis - a common cause of lameness. After lameness, colic was the next most common cause of euthanasia, with 21% of owners citing this as the main reason.
In an earlier stage of the project, the researchers had found that half the geriatric horses surveyed suffered from lameness, but only 24% of owners reported the problem.
Dr Pinchbeck said: "Although lameness is common in older horses, this is the first study to quantify its contribution to their mortality.
"Owners are often missing the early signs of lameness in their horse, which means the condition isn't being managed and may deteriorate faster."
Dr Pinchbeck said it would be useful to carry out further research into lameness in geriatric horses to find out the main causes of lameness and how these may be prevented or treated.
The research team also found that half of the horses euthanased were suffering from concurrent health problems and these influenced the owner's decision to euthanase in 43% of cases. The most frequently reported additional health problems were musculoskeletal problems, such as arthritis.
The mortality rate among the horses surveyed was 11 per 100 horse-years at risk, meaning that if 100 geriatric horses were followed for a year, an average of 11 would die. The mortality rate for horses over 30 years of age was over five times the rate than in horses aged 15 - 19 years.
Jeanette Allen, Chief Executive of The Horse Trust, said the data provided by this research is likely to provide useful information for both horse owners and vets to enable them to improve the welfare of older horses. She said: "As there are a significant number of geriatric horses in the UK, it is vital that we understand more about the health problems that affect them. We hope that more owners of older horses will give their horse an annual health-check to enable the horse to have a longer, healthier life."
The research was published in the September 2011 issue of Preventive Veterinary Medicine.
Hill's has launched 'Lose 60 Tonnes in 6 months', a campaign to help clients get their pet to a healthy weight.
Sixty tonnes is equivalent to the weight of twelve elephants, which is a huge target. Hill's says that if every practice makes a small contribution, it can be achieved.
Hill's support includes a public relations pack which the company says contains everything veterinary surgeons and nurses need to help raise awareness and encourage pet owners to bring their pets in for a weight assessment. The pack includes proforma press releases and guidance on how to cultivate a mutually beneficial relationship with local media. There is also a 'Lose 60 tonnes in 6 months' point of sale kit that includes a poster, stickers and a noticeboard kit for clinics, to drive awareness while clients wait for consults.
As part of the campaign, Hill's is also hosting a series of nurse webinars on weight management and offering additional support material such as consult room posters, weight clinic packs and pet tape measures, an item often requested by nurses. There are also promotional offers available through Hill's Territory Managers, subject to stock availability.
Hill's Customer Marketing Manager, Sara Locke MRCVS said: "We feel it is important to support practices at the grass-roots level and to develop a campaign that will have real meaning within the local community. I hope practices will get behind it, engage with pet owners and as a result, gain new clients. They are also helping thousands of pets live longer and happier lives."
Further information is available from local Hill's Territory Managers or by calling Hill's on 0800 242438 or in ROI 1 800 626002.
The Blue Cross has award presented its Veterinary Nurse of the Year award to Terri-Ann Corbett for her commitment to improving animal welfare, both within her veterinary practice and among the local community in Wrexham, Clwyd.
The award was presented on Saturday 8 October during the BVNA annual congress in Kettering, Northamptonshire by Noel Fitzpatrick, BBC1's 'Bionic Vet', and Tracy Genever, Blue Cross education development manager.
Tracy Genever said: "The Blue Cross presents the Veterinary Nurse of the Year award to recognise the hard work and dedication of vet nurses in the UK. So many vet nurses go the extra mile to not only help pets in their care but work tirelessly to educate pet owners in the whole of their community. We congratulate Terri-Ann who truly deserves to be this year's winner. She should feel very proud to have secured such obvious admiration and affection from her colleagues and clients."
Terri-Ann received an impressive 26 nominations from her colleagues at Daleside Veterinary Care Ltd, practice clients and her husband, Nigel.
Sharon Price, Practice Manager at Daleside said: "Terri-Ann is the consummate professional with bags of enthusiasm. She regularly brings innovative ideas to the practice and her clients always speak highly of her relationship with their animals. I am delighted that her efforts have been recognised through this award and hope she feels the value she truly deserves."
Terri-Ann said: I always wanted to be a veterinary nurse from as young as I can remember and never even thought I would get this far, so I was speechless when I found out I had won this award. Not only is it touching but such a great privilege, it really is a once in a lifetime achievement, Thank you so much."
The British Veterinary Association has criticised the conclusions drawn by the Gloucestershire Wildlife Trust in its report on badger vaccine deployment.
The report considers the effectiveness of the Trust's programme of deploying the injectable BadgerBCG vaccine in seven nature reserves covering only 170 hectares (1.7 sq km) during the summer.
It concludes that the badger vaccine is a viable alternative to culling in the battle against bovine TB, but according to the BVA, does not give evidence to support this claim.
Carl Padgett, President of the BVA, said: "We welcome the initiative by the Gloucestershire Wildlife Trust to investigate the deployment of the badger vaccine but this work must not be confused with an investigation into the effectiveness of the badger vaccine in reducing or eradicating bovine TB.
"To conclude from this report that the badger vaccine is a viable alternative to culling in eradicating TB is unrealistic at best and spin at worst.
"The fact remains that the vaccine has no protective effect on infected badgers and we know that at least 30-40% of badgers within an area will be infected. Many young badgers will be infected before they can be trapped and injected.
"In terms of the practicalities of deployment this report provides interesting information but we will learn much more as a result of Defra's Badger Vaccine Deployment Project which is looking at a much larger area of 100 sq km.
"Vaccination of badgers certainly has a role to play in an effective TB eradication programme but it is only one tool in the toolbox."
The RCVS Veterinary Nurses Council has celebrated the 50th anniversary of veterinary nursing at the House of Commons with a call for statutory regulation for the profession.
At a Golden Jubilee event hosted by Mr Roger Gale MP, Veterinary Nurses Council Chairman Liz Branscombe drew attention to the fact that there is no legal protection for the title 'veterinary nurse', despite qualified nurses playing "a unique role in the practice team".
This effectively means that anyone could work in a veterinary practice as a nurse, without taking the three- or four-year training required for Listed or Registered Veterinary Nurses.
Liz said: "We believe that the nation's animals and their owners deserve better than this. And it's not just a question of animal welfare: public health is at risk from the incorrect use of medicines - for example, the well documented development of antimicrobial resistance."
The Veterinary Surgeons Act 1966 was put in place only five years after the introduction of veterinary nurse training and too soon to fully recognise the potential of veterinary nursing as a profession in its own right.
As an interim measure, the RCVS has put in place a non-statutory Register for Veterinary Nurses, to which 86% of eligible nurses have signed up. Registered Veterinary Nurses agree to follow a code of conduct, keep their skills and knowledge up to date and abide by a disciplinary system. However, it is not possible for the College to bar those removed from the Register for serious professional misconduct from working as a veterinary nurse.
The Register also does not address the misuse of the title 'veterinary nurse' by unqualified people.
Liz asked MPs present at the House of Commons reception to sign up to an Early Day Motion tabled by Andrew Rosindell MP, which calls for statutory regulation for the veterinary nursing profession.
Others are urged to sign a petition on the Government's website which has been mounted by the British Veterinary Nursing Association and is supported by the College and the British Veterinary Association: http://epetitions.direct.gov.uk/petitions/18700.
The issues are being considered by the RCVS Veterinary Nurses Legislation Working Party and the group's recommendations will feed into the wider work of the RCVS Legislation Working Party, which will be reporting to the Defra Minister of State in the summer of 2012 with proposals as to how statutory regulation could be provided for a range of veterinary services, including veterinary nursing.
Virbac has announced that it is to increase production of cat vaccines at its French plants to help practices in the UK manage a shortfall in supply.
The predicted shortfall follows warnings by other manufacturers of stock shortages of between three and six months.
Virbac, which makes the Feligen RCP, Leucogen and Leucofeligen cat vaccines, says it wants to reassure practices that it will do its utmost to ensure continuity of supply during this period and is urging them to order as usual and not stockpile product, which could exacerbate the problem.
Simon Boulton MRCVS, Product Manager for Virbac's vaccine range, said: "Our priority is to keep stock flowing to our existing customers. With this in mind, we've now ceased to supply wholesalers with our cat vaccines. Once wholesaler stocks have been depleted, we ask customers to contact us directly so that stock can be despatched to them from our own warehouse.
By taking this step, we can manage our own stocks effectively and, while we'll be putting our existing customers first, we also stand ready to help supply the rest of the veterinary sector during this period. As a primary manufacturer of vaccines, we're well placed to react quickly to stock shortages and expect to have significantly increased supply by November."
Practices wanting further information should contact their Virbac Territory Manager. Direct orders to the company should be made by calling Virbac on 01359 243243 and selecting Option Three (Direct Orders).
The RCVS Veterinary Nurses Council has decided that the College should cease being an awarding body next year, which means it will no longer offer the vocational Level 3 Diploma in Veterinary Nursing.
The College says it will ensure that the Diploma continues to be available by transferring the intellectual property associated with the qualification, such as the question banks and systems, to another larger awarding body, in a move which is likely to take effect for the beginning of the 2012 academic year.
According to the College, this decision reflects recent changes in the regulatory Conditions of Approval for awarding bodies, which it would have been hard for the College to meet while continuing to offer the Diploma cost-effectively. The changes mainly relate to potential conflicts of interest between the College's primary role, as professional regulator that safeguards standards within the veterinary professions, and its role as an awarding body. The standards-setting role includes the regulation of education and training leading to the veterinary and VN registers, and it was felt that the College could no longer exercise this role effectively if it was also an awarding organisation, as it might be suspected of treating its internal qualifications more favourably, or of obstructing competitors.
Although the College says this has not been a problem in the past, the rules are now more stringent, and the costs of setting up a fully independent awarding body would be prohibitive.
The market for the Diploma is also likely to fragment in the future, with three other awarding bodies expressing an interest in offering a Level 3 Diploma. Any reduction in the number of students taking the RCVS Level 3 Diploma would further push up the costs, potentially making the RCVS Awarding Body unviable. A larger awarding body can take advantage of economies of scale across a range of awards in a way that the RCVS cannot.
Colonel Neil Smith, Chairman of the RCVS Awarding Body Board said: "The RCVS has been offering vocational qualifications since 1998 and the decision to cease being an awarding body has not been taken lightly.
"We have taken this decision in order to focus on our core responsibilities of professional regulation and standard setting. However, we remain committed to maintaining the Diploma, which has been carefully developed by the RCVS and the profession. This move ensures that it will stay in safe hands."
The name of the awarding body to which the qualification will be transferred has not yet been announced because the process is not complete. However, the College says it felt it was important to give those involved with the delivery of training as much notice as possible of the change. More information, and the change-over plan, will be released in due course.
Libby Earle, RCVS Head of Veterinary Nursing said: "Our priority will be effecting a smooth transfer for students, Colleges and training practices, and we are confident that the impact of the change will be minimal. Furthermore, it will be a condition of the transfer that the veterinary profession continues to have a say in the future development of the qualification."
Those students still in the process of completing the old NVQ qualifications, the accreditation of which is due to run out in 2013, will continue to be serviced by the RCVS.
As the professional regulator, the College will continue to issue RCVS certificates and badges to those who have successfully completed a registerable qualification - such as an approved vocational qualification run by another awarding body, or an RCVS-recognised veterinary nursing degree.
The Advanced Diploma in Veterinary Nursing will be unaffected by the change as the qualification is awarded by the College under its Royal Charter powers.
The RCVS has opened a consultation on the future of veterinary specialisation, which includes a proposal that the use of postnominals and titles by veterinary surgeons should be rationalised in order to avoid confusion amongst the public.
The proposals are submitted for comment by the RCVS Specialisation Working Party, which is chaired by former Chief Medical Officer Professor Sir Kenneth Calman.
The Working Party's review was precipitated by a finding that the structure of veterinary specialisation is "confusing and opaque" to both animal owners and the profession (Unlocking Potential - a Report on Veterinary Expertise in Food Animal Production, by Professor Philip Lowe, 2009).
The Working Party has explored the routes to RCVS Recognised Specialist status. It has also looked at the use of 'specialist' more broadly, given the fact that it is not a protected term in the veterinary field, and has considered animal owners' expectations of a 'specialist'.
The Working Party also makes proposals for encouraging more veterinary surgeons to become specialists, given that there are currently only 319 on the RCVS List of Recognised Specialists, out of a UK practising arm of the profession of some 17,400 veterinary surgeons.
The proposals from the Working Party could have far-reaching impact. One suggestion is that all those meeting the criteria for specialist status would also become Fellows of the RCVS (FRCVS) - a status currently only held by those who complete a thesis or exam, or who qualify on the basis of 'meritorious contributions to learning'. There are also proposals that the term 'RCVS Recognised Specialist' be dropped and replaced with the much simpler term 'specialist' or 'veterinary specialist'.
Further proposals include the introduction of a 'middle tier' of veterinary surgeons - potentially to be called 'advanced practitioners' - who would be below full specialist status and subject to periodic revalidation.
There are also recommendations that veterinary surgeons should be obliged to explain referral options to their clients, including the level of expertise of those to whom they are referring cases.
The future of the RCVS subject boards, which currently manage the various Certificate and Diploma examinations, is also considered in the proposals.
The emphasis throughout is on simplification and improvement, according to Professor Sir Kenneth Calman, who said: "New legislation to introduce statutory registration for veterinary specialists would no doubt make things clearer, as it is for doctors and dentists, but, in the meantime, we believe there are a number of actions which the RCVS could take to improve matters."
The consultation paper can be downloaded from www.rcvs.org.uk/consultations, and comments are welcomed from members of the public, veterinary surgeons and veterinary nurses. The closing deadline for comments, which should be sent to RCVS Head of Education, Freda Andrews, on f.andrews@rcvs.org.uk, is Friday 9 December.
Comments received will be considered by the RCVS committees and Council in early 2012.
Bayer Animal Health has launched a next generation fluoroquinolone antimicrobial - Veraflox (pradofloxacin) - for the treatment of bacterial infections in cats and dogs.
Bayer Animal Health's marketing manager Dr Markus Edingloh said: "Veraflox, with its molecular compound pradofloxacin, developed exclusively for veterinary medicine, marks a major leap forward in veterinary antibiotic therapy and patient care.
"Veraflox has an enhanced spectrum of antimicrobial activity which encompasses Gram-positive and anaerobic bacteria. In addition, Veraflox has demonstrated high levels of bactericidal activity against target pathogens including activity against dormant bacteria typically found in chronic infections."
For cats, an oral suspension is available in which a fine-grained ion exchange agent binds to the antibiotic, apparently allowing it to pass the cat's taste buds undetected. Bayer says this innovation has been adopted specifically to ensure the product is palatable to cats, and help ensure owner compliance. The oral suspension comes with a syringe with both millilitre and gramme graduations, to help ensure accurate dosing.
Veraflox oral suspension is indicated for the treatment of upper respiratory tract infections, wound infections and abscesses. The 15mg tablet is also licensed in cats for treating upper respiratory tract infections.
Bayer says that in addition to its other indications, Veraflox is also very effective at combatting anaerobic bacteria that play a major role in aggressive bone destruction in canine periodontal disease, and it is the first fluoroquinolone to be licensed in dogs for the adjunctive treatment of severe infections of the gingiva and periodontal tissues.
In addition to its dental claim for dogs, Veraflox is also indicated for the treatment of wound infections, superficial and deep pyoderma, and acute urinary tract infections. It is given to dogs as a once-daily flavoured tablet.
Dr Edingloh added: "The unique chemistry and way in which Veraflox works gives it superior antibacterial activity compared with existing fluoroquinolones. In addition, during field studies, Veraflox was shown to be superior to other leading antibiotic products.
"Pradofloxacin has been proven to have a wide spectrum of activity, outstanding antibacterial activity, and an excellent safety margin. Its pharmacokinetic features ensure this active ingredient can rapidly get to the site of infection, at which it has a great impact on the pathogen population.
"One of the most common reasons for treatment failure where antibiotics are concerned is lack of owner compliance. The availability of Veraflox as an oral suspension with a graded syringe for cats, will enable more accurate dosing, far easier administration and so ensure higher cure rates.
"The launch of Veraflox is the first major advance in its class, since the introduction of Baytril, the first veterinary fluoroquinolone, over 20 years ago. Veraflox provides vets with more predictability, reliability and peace of mind, especially in difficult to treat infections."
For further information on Veraflox, please contact your Bayer representative or call 01635 563000.
VetUK, an online supplier of pet products and veterinary prescription only medications, has announced that it now processes over £750,000 worth of online transactions per month.
The point of the press release was to highlight that this has been achieved using paypoint.net to handle the tens of thousands of orders that VetUK says it receives each month, and process the payments.
However, it does also highlight the ever growing competition to veterinary practices from online. You might like to check VetUK's POM prices here.
Vetoquinol is launching Cimalgex, a new NSAID for dogs this month.
Cimalgex (cimicoxib) is a new second generation COX-2 inhibitor which can be used for the treatment of pain and inflammation due to osteoarthritis and the management of peri-operative pain associated with orthopaedic and soft tissue surgery, for which it can be given two hours before surgery and continued for 3-7 days post surgery.
Vetoquinol says that an important consideration in treating dogs with osteoarthritis, many of which are geriatric, is that there are no contraindications to using Cimalgex in patients with mild to moderate renal impairment.
According to the company, field trials showed that over 90 per cent of per owners and vets identified that animals experienced excellent analgesia post operatively*.
Available in a chewable, splitable tablet, Cimalgex can be given with or without food.
Vetoquinol says that the excellent tolerability, efficacy profile and ease of use of Cimalgex means that veterinary patients could benefit from pain relief in situations where clinicians are worried about the risks versus the benefits of prescribing a NSAID for pain management.
Further information about assessing pain and decision making when it comes to prescribing NSAIDs, will be presented in a free webinar on 19th October at 8.30pm. To register go to www.thewebinarvet.com/vetoquinol and enter code CIM1.
Reference*E. Grandemange: Field evaluation of the efficacy and the safety of cimicoxib in the relief of peri-operative pain in dogs; 2008, study number n°3008C2F1
The RCVS is to launch a new badge for registered veterinary nurses (RVNs) at the British Veterinary Nursing Association Congress later this week.
The launch ties in with the 50th anniversary of veterinary nurse training, and highlights the fact that RVNs, while qualified to the same level as their listed colleagues, stand apart because they additionally agree to account for their professional practice and keep their skills and knowledge up to date.
The non-statutory RCVS Register of Veterinary Nurses was introduced in 2007, and RVNs abide by a code of professional conduct, commit to continuing professional development and, from 1 April this year, can be taken to task via a disciplinary system.
The new badge builds upon the old version but with the word 'registered' underneath. Plans for a more dramatic departure from the existing badge were dropped when the College saw the affection in which veterinary nurses held the traditional antique silver and red-enamel badge, introduced in 1984.
Liz Branscombe, Chairman of the RCVS Veterinary Nurses Council said: "There is currently no legislation to protect veterinary nurses' title and area of work, but we have not stood still and the Register shows a real commitment to developing our status as professionals. We need to ensure this commitment is recognised by clients and others in the veterinary team, and hope the new badge will make it easier to identify who is professionally accountable."
All those veterinary nurses qualifying since 2003 automatically became registered and those qualifying earlier could choose to do so. Currently there are 8,682 registered veterinary nurses, and 1,463 remain on the unregulated list.
The new badge will be presented to all those qualifying since 4 July 2011, and those registering earlier can purchase it for £15 (to cover the cost of the badge and engraving it with the RVN's individual number) up until the 31 January 2012. RVNs are under no obligation to purchase the new badge, although the College hopes that many will choose to do so to mark the step forward which the profession has made.
The Veterinary Nurses Council is developing proposals for statutory regulation to put to the Department for Environment, Food and Rural Affairs. Meanwhile, Roger Gale MP will host a reception at the House of Commons on 11 October to celebrate the first half-century of veterinary nursing, and raise awareness of the benefits for animals and their owners of legal recognition of veterinary nurses.
Veterinary nurses attending BVNA Congress in Kettering are encouraged to visit the RCVS stand in the gallery area to take part in a 50th anniversary quiz, collect their chocolate version of the new badge, and find out how to obtain the real thing. Liz Branscombe will also be making a presentation on Saturday 8 October about the new disciplinary system for registered veterinary nurses.
CPD Solutions has launched a webinar club just for veterinary nurses, available to view at www.veterinarywebinars.com.
Susie Coughlan, Managing Director at CPD Solutions said: "We know that for nurses, CPD can be a big challenge. Time and cost are a real consideration and many nurses are not able to travel to distant venues to study the topics of their choice due to family or work commitments. In winter, travelling alone in cold and dark conditions becomes even less attractive. This webinar club offers a way for nurses to access relevant high quality CPD, safely, easily and cost effectively, to fit with their busy lifestyles."
The nurses club provides a monthly live webinar, in the afternoons or evenings. All webinars are also available for club members to view after the live event at their convenience. Susie said: "We decided to limit the available webinars to one a month during the annual membership period because with the best will in the world, many nurses have only a limited time and money available to spend on CPD and there is very little point in paying for a multitude of webinars that they will never have the time to attend. Part of the appeal of webinars is their low cost and value for money, although we know many nurses put flexibility as to when and where they view as the most exciting attribute of webinar clubs. It's another small but important step towards helping nurses maintain and build upon their professional skills."
CPD Solutions is offering a special launch price of £247 + VAT for veterinary nurses who join before 10th October, which represents a saving of £80 on full price membership. In addition, each membership comes with two log-ins, meaning that two nurses can benefit from the nurse webinar club for the price of one. The launch offer also includes a free CD/DVD which CPD Solutions says is packed with content relevant to the club topic. All members will also have access to four webinars from the recent archive.
For more details or to join a webinar club visit http://www.veterinarywebinars.com/ or call 0151 328 0444.
Parasitologists from ESCCAP (European Scientific Counsel Companion Animal Parasites) have been voicing their concern over the implications of the imminent changes to the UK's DEFRA-run Pet Travel Scheme (PETS).
Under the new regulations, which take effect from Jan 2012, tick control will no longer be mandatory. According to ESCCAP, a recent study has demonstrated that a population of exotic tick species has already become established in the south-east of England1. With up to 15,000 animals travelling under PETS each month, the possibility of exotic ticks (and their associated tick-borne diseases) entering and establishing in the UK becomes increasingly likely. The European Parliament has yet to rule on mandatory tapeworm control. The decision will impact on the future distribution of, and disease threat from, Echinococcus multilocularis.
ESCCAP UK is advising all veterinary surgeons to discuss the risks with their clients and to ensure they make an informed decision about tick control when the new legislation comes into effect.
In addition, the UK branch of ESCCAP is holding a free seminar in Bristol on 28th October to highlight the role that veterinary practices can play in helping clients understand how the changes could impact upon their pet's health.
ESCCAP says the seminar will provide all the information clinicians need to have an informed dialogue with clients. Presentations will provide an overview of the impact of the changes to PETS in relation to rabies, Echinococcus and ticks, as well as advice about how to communicate the information to pet owners and the tools and support available.
Additional support includes ESCCAP UK's website http://www.esccapuk.org.uk/, which offers updates on the PETS situation, guidelines for parasite control programmes and podcasts for veterinary surgeons, nurses and pet owners.
The seminar takes place at Engineers' House, The Promenade, Clifton Down, Bristol BS8 3NB.
To register, telephone: 01684 568998, or email: info@esccapuk.org.uk
Reference1. Smith F D, Ballantyne R, Morgan E R, Wall R (2011) Prevalence, distribution and risk associated with tick infestation of dogs in Great Britain. Medical and Veterinary Entomology. doi: 10.1111/j.1365-2915.2011.00954.x
Petplan has announced the finalists for the Petplan Insurance Advisor Award. This award recognises the hard work and dedication that Petplan Insurance Advisors (PIAs) do to highlight the importance of insurance to pet owners so that they are protected financially.
Three veterinary professionals have been short-listed as finalists:
The finalists were judged by Petplan Business Developers Lisa Allen and Spencer Jones.
Spencer said: “At Petplan we work closely with vet practices to educate them about pet insurance so that they are able to give their customers informed and up-to-date advice. This year it is great to see the dedication and competence that each finalist has applied to providing their customers with great service and support.”
The winner will be announced at the annual BVNA Congress, taking place from Friday 7th - Sunday 9th October 2011, and will receive a 16GB Ipad2 with WiFi, worth £399.
For information on how to become a PIA contact Vetline on 0800 316 8800 or alternatively log onto www.Petplanpia.co.uk.
To find out more about Petplan visit www.petplan.co.uk
Norbrook has launched a new iPhone app designed to give veterinary professionals essential pharmaceutical product information at the touch of a button.
The Norbrook Veterinary Excellence Tool includes information on the company's full range of animal health medicines including pharmaceutical presentation, uses, dosage and administration, withdrawal periods, contraindications & warnings and pharmaceutical precautions.
Mr Jorge Rodrigues, General Manager at Norbrook said: "Norbrook is committed to providing the best possible service to our customers. Time is a precious commodity for veterinary professionals and with the range of products on the market it can be very time-consuming to access essential product information. We have designed the Norbrook VET app to give our customers a quick and easy reference tool for all our products with the facility to filter searches for product information by species, category or brand. And of course the beauty of the iPhone app is that the information is accessible anytime, anywhere so if a customer is out at a client's premises, in their practice or at home, the information is readily available."
The Norbrook VET app also has a facility which will keep users up-to-date with relevant industry and company news and a dedicated Contact Us section which will allow customers better communication channels with the company.
Katie Norton, Web SEO Marketing Co-ordinator said: "It is our intention that the Norbrook VET app will become a key communication channel with our customers. The app will be updated regularly and we will continue to add new features to enhance the service we offer to our valued customers."
The Norbrook VET iPhone App is available to download direct from the iTunes store.
A survey of 246 veterinary surgeons and nurses attending a lunch and learn webinar sponsored by Supreme Petfoods has revealed that they rate high fibre as the most important factor in making a recommendation for rabbit or guinea pig food.
High fibre was the top factor for 53% of respondents and rated as being much more important than monocomponent kibbles (27%), or a recommendation by an exotics expert (18%).
Supreme says it has addressed this concern by increasing the fibre content of its Science Selective Rabbit food to 23% fibre - the highest of any concentrate for small furries in the UK. The new VetCarePlus range, based on the monoforage technology developed by the company, contains up to 34% fibre. Fibre is vital for small furries, playing an active role in gastro intestinal health, dental health, weight management and behavioural factors.
The survey also revealed that vets and nurses are feeling optimistic about the impact of small furries on veterinary practice. 70% of respondents felt that, even in the face of the recent recession, small furries/exotics had made a growing contribution to their business profits over the last five years and 90% felt that there was potential for them to make an even bigger contribution to practice profits in the future. The biggest barrier to more small pets being brought forward for treatment was felt to be the cost of treatment relative to the cost of the pet - 55% felt that this was the most significant stumbling block - but another 45% felt that lack of education and an inability to recognise illness were the main factors.
Supreme's Marketing Manager Claire Hamblion has recently launched a trial programme in a limited number of practices to provide the tools needed to help grow the small pets sector. She said: "Our experience to date indicates that having the right tools and providing a warm welcome to owners of small furries that projects a willingness to treat them, can make a difference. We would love to hear more from those who have successfully grown this part of their business and those who are looking to expand their capabilities in this exciting area." Interested parties, or those who would like to pre-register for the further roll out of Supreme's business programme can send an email with their contact details to b2b@supremepetfoods.com.
The company says it has been delighted by the positive response to its lunch and learn webinar format, and more events are being scheduled for the winter months. Those interested in attending future events, or receiving educational material, can register their interest by email at cpd@supremepetfoods.com to receive priority notification of dates and availability.
Pfizer is giving away a free equine weigh tape with every purchase of Equest & Equest Pramox (while stocks last), to help encourage accurate treatment against encysted small redworms this season.
According to the company, Equest & Equest Pramox are the only wormers in the UK that treat encysted small redworm in a single dose. Using a weigh tape to work out their horse's weight will help your clients avoid under dosing, which increases the risk of resistance development.
Pfizer says small redworms are the most common worms found in horses today. They can pose a very serious health risk to horses and it's important for owners to make sure that they are treated properly during the autumn or early winter.
Small redworms can grow up to 2.5cm in length and are thin and reddish in colour. Small redworm eggs are passed in the faeces and then hatch on pasture and continue to develop into more advanced larval stages before being ingested by the horse as it grazes. The larvae burrow deeply into the wall of the gut where they encyst and may account for up to 90% of the redworm burden in the horse1. Encysted small redworm will not show up in a Faecal Worm Egg Count - even if the horse has shown a negative or low count it could still be harbouring several million encysted small redworms2.
Encysted small redworms can remain dormant inside a horse for up to two years, but they usually 'wake-up' in late winter or early spring, developing and emerging from the gut wall all at the same time. In severe infestations mass emergence can lead to a disease syndrome known as 'larval cyathostominosis', causing diarrhoea and colic with up to a 50% mortality rate3. Young horses of less than six years of age can often be at higher risk of the disease3 but small redworm can cause life-threatening illness at any time of year and in any age of horse.
Ben Gaskell, Pfizer's veterinary adviser said: "Treating encysted small redworms successfully in the late autumn or early winter is important to avoid the risk of larval cyathostominosis. It's important to advise your customers to choose a product that is licensed to treat the worms they are targeting and that they give the correct dose, by weighing their horse beforehand, as this will help preserve the efficacy of the drug used."
Pfizer's Does your wormer measure up campaign is backed with point of sale materials and a media campaign. To receive a free weigh tape, valued at £7 your clients need to buy a tube of Equest or Equest Pramox, fill in an application form and send Pfizer the batch and expiry flap from the pack. Pfizer will then send them a FREE Weigh Tape while stocks last.
For further information contact your Pfizer Account Manager.
References
1. Bairden K. et al (2001) Veterinary Record 148, 138-1412. Dowdall S.M.J. et al (2002) Veterinary Parasitology 106, 225‑2423. McWilliam H. et al (2010) International Journal for Parasitology 40, 265-275
The RCVS Charitable Trust is offering up to 5 grants to veterinary nurse training centres to purchase equipment worth up to £5,000.
Applications may be made for equipment which is directly used for veterinary nurse training of care and treatment of animals. All RCVS accredited UK veterinary nurse training centres are eligible to apply.
Tracy Mayne, RVN and Trustee, said: "Traditionally we directed our equipment grants only to the veterinary schools, but last year we extended the eligibility to include veterinary nurse training centres, and in 2011 we decided to dedicate the funding solely to veterinary nurse training, as part of celebrating 50 years of the profession.''
All applications must be received by 5pm on Monday 31 October 2011.
Further information including full application criteria, is available from www.rcvstrust.org.uk/grants/
Virbac Animal Health has announced that registrations on BackHome BioTec, the company's microchip identification service, were moved to the Petlog Database with effect from Monday 12 September 2011.
Virbac says it moved to the UK's largest independent microchip registration database in order to offer an enhanced level of service and support, both to veterinary staff and pet owners.
Practices using the BackHome BioTec system are being asked to log onto www.virbacbackhome.co.uk to create a new account.
Gillian Brown, Product Manager for BackHome at Virbac, said: "BackHome has established itself as a popular, cost-effective and easy to use microchipping system. We believe that in appointing Petlog to manage our registrations we will now be offering a 'best of breed' service for veterinary staff and pet owners.
"We're extremely grateful to Celia Walsom, Petlog Executive, and her team. They have demonstrated unfailing energy, expertise and total dedication to ensuring this move has run smoothly and effectively for all our customers. I am confident that they will benefit from Petlog's commitment to provide a comprehensive identification service which is easy, convenient and secure to use.
"All our existing customers need to do is go to the new website (www.virbacbackhome.co.uk/) and set up an account - it's a simple and quick process. We'll also be providing a range of promotional materials to help them communicate the change to their own clients."
Petlog is owned and managed by the Kennel Club. Virbac says it is fully data compliant and defers income to ensure it can honour its lifetime promise to pet owners. Its Lost and Found helpline is available 24/7, 365 days a year and it is also a founder member of the European Pet Network.
Further information on BackHome BioTec is available on the new website, which also contains a direct link to Petlog.
For further information about BackHome BioTec, please contact your Virbac Territory Manager or call the company on 01359 243243.
Virbac Animal Health is launching an initiative to highlight the prevalence of Benign Prostatic Hyperplasia (BPH), a condition suffered by more than 80% of entire male dogs over the age of five1.
The campaign will take place during November - or 'Movember' as it's called by the thousands of men who grow moustaches during the month to raise funds for male prostate and testicular cancer. Virbac says it hopes the campaign will remind dog owners that men are not the only ones to suffer from prostate disorders.
As part of the campaign, the company will be providing participating practices with promotional materials including free dog leads, owner educational and display materials, a press release for local media and practice educational materials.
Chris Geddes MRCVS, Virbac Product Manager, said: "It's estimated that 20% of the country's eight million dogs remain uncastrated throughout their lives. As dogs age, their prostates enlarge, eventually causing symptoms including constipation, lameness and difficulties in urination. However, most of the time clinical signs are absent or vague so diagnosing BPH can be a challenge."
According to Virbac, the traditional rectal examination technique can be an ordeal for both dog and clinician. It's also sometimes inaccurate even in experienced hands and is impossible in very small or large breeds. As a solution, the company has recently introduced Odelis CPSE, the first ELISA test to screen for, diagnose and monitor BPH, available from three UK diagnostic laboratories. The company says it's a cost-effective, precise and reliable alternative to rectal palpation. Virbac also offers Ypozane, a simple tablet treatment for BPH, which takes effect within a week and lasts for six months.
Chris added: "BPH is a serious threat to the health of entire dogs as they get older but owners are often unaware of the potentially serious health problems it can cause if left untreated.
"We hope that, by running our Prostate Awareness Campaign at a time when the media spotlight is already on the dangers of prostate cancer in men, we can help spread the message that owners should also be monitoring older dogs for signs of prostate disease.
"We're providing practices with all the materials they need to promote the campaign in their locality and hope that those getting involved will find it effective in terms of bringing dog-owning clients into the practice for advice on BPH."
For further information on the Prostate Awareness Campaign and to get your free pack please contact your Virbac Territory Manager or contact the company direct on 01359 243243.
Reference1. O'Shea J.D. Studies on the canine prostate gland: Factors influencing its size and weight. J. Comp. Pathol. 1962 72: 321-331.
The NOAH Code of Practice Committee, chaired by Mr Guy Tritton, has found Dechra Veterinary Products in breach of three items of the NOAH Code, following a complaint.
The complaint related to an advertisement and detailer promoting Felimazole with the wording "Are you taking a heavy-handed approach to hyperthyroidism?" and "with Felimazole, you don't have to!"
The Committee took the view that by implication this referred to Vidalta because Vidalta is the only other licensed oral treatment on the market for hyperthyroidism.
As a result, the Committee found both promotions in breach of Clause 4.3 because of the implication that Vidalta is less safe than Felimazole.
The Committee did not consider the promotions disparaged the manufacturer as there is no evidence to show it is unsafe.
The Committee also found that the table in the detailer (page 4) suggesting that one dosage of 5 mg per day of Felimazole has the same efficacy as two doses of 2.5 mg, (which is contrary to the dosing statement within the SPC: "If, for reasons of compliance, once daily dosing with a 5 mg tablet is preferable, then this is acceptable although reduced efficacy can be expected compared to a twice daily regime.") was misleading, contrary to Clause 4.3 of the Code.
Full details of the Committee's rulings are on the NOAH website at www.noah.co.uk/code. The full report of this particular case will be available shortly.